Eric Devroe Email & Phone Number
@acrivon.com
3 phones found area 617 and 415
LinkedIn matched
Who is Eric Devroe? Overview
A concise factual answer block for searchers comparing this professional profile.
Eric Devroe is listed as Chief Operating Officer at Acrivon Therapeutics at Acrivon Therapeutics, Inc., based in Greater Boston, United States, United States. AeroLeads shows a work email signal at acrivon.com, phone signal with area code 617, 415, and a matched LinkedIn profile for Eric Devroe.
Eric Devroe previously worked as Chief Operating Officer at Acrivon Therapeutics, Inc. and SVP, Business Operations at Acrivon Therapeutics, Inc.. Eric Devroe holds Ph.D., Biological Chemistry & Molecular Pharmacology from Harvard University.
Email format at Acrivon Therapeutics, Inc.
This section adds company-level context without repeating Eric Devroe's masked contact details.
AeroLeads found 1 current-domain work email signal for Eric Devroe. Compare company email patterns before reaching out.
About Eric Devroe
Life sciences executive and entrepreneur with diverse industry experience spanning the development of therapeutics, medical devices, diagnostics, biofuels, and research tools. Founding team member of multiple start-up companies.
Listed skills include Biotechnology, Drug Discovery, Strategy, Lifesciences, and 28 others.
Eric Devroe's current company
Company context helps verify the profile and gives searchers a useful next step.
Eric Devroe work experience
A career timeline built from the work history available for this profile.
Svp, Business Operations
Joined the founding team at seed financing stage, helping build and advance Acrivon through an exclusive license agreement for prexasertib from Eli Lilly, fundraising milestones (Series A, B, IPO,PIPE), a companion diagnostic partnership with Akoya Biosciences, launch of the company's ACR-368 clinical studies, and continued development of the AP3 platform.
Founder & Bod
Co-founded a founder-financed immuno-oncology focused biotech with an option agreement to key technology and insights out of MD Anderson Cancer Center.
Strategic Advisor
Working with platform and executive leadership, developing business plans for several Moon Shots initiatives including precision medicine and cell therapy. Scouting for development and commercialization opportunities.
Founder & Ceo
Opsonix is developing pathogen-extracting therapies to transform the treatment of bloodstream infections and sepsis. The company’s proprietary expertise is creating engineered pathogen-capture proteins derived from opsonins, which are natural components of our innate immune system that bind to and help clear all types of infectious pathogens and toxins.
Entrepreneur In Residence
Developed the product development, business, and fundraising strategy for Opsonix, formally launching the company in October 2015 following completion of an $8M Series A financing round.
Executive Director
Led business and strategy development for MD Anderson's Institute for Applied Cancer Science; P&L responsibility for the institution's $75M investment in this dedicated drug discovery and development platform.
Vp, Business And Strategy Development
Founding employee; led Metamark's efforts in licensing (in- and out-), developing partnerships, and building the IP strategy and portfolio. Forged enabling alliances with HistoRx, Definiens, and a $365 million therapeutic target collaboration with Janssen Biotech.
Venture Associate
Member of Flagship's venture creation team. Founding team member of renewable fuels company Joule Unlimited, Inc (fka Joule Biotechnologies) and the therapeutic company concept, NetEffect Pharmaceuticals, Inc..
Associate Director
Served in a variety of scientific and operational leadership roles of increasing responsibility, and led the manufacturing operations team tasked with construction of complex and repetitive DNA sequences.
Scientist
Research scientist tasked with expanding microRNA detection offerings. Developed and launched the mirVana qRT-PCR miRNA detection kit. Investigated diagnostic and therapeutic applications of miRNAs, contributing to intellectual property forming the basis of two spin-outs, Asuragen and Mirna Therapeutics.
Graduate Student
Identified and investigated novel human proteins that interact with HIV-1 proteins. Developed the first described retroviral vector to stably express siRNA in mammalian cells.
Eric Devroe education
Ph.D., Biological Chemistry & Molecular Pharmacology
B.S., Microbiology
High School
Frequently asked questions about Eric Devroe
Quick answers generated from the profile data available on this page.
What company does Eric Devroe work for?
Eric Devroe works for Acrivon Therapeutics, Inc..
What is Eric Devroe's role at Acrivon Therapeutics, Inc.?
Eric Devroe is listed as Chief Operating Officer at Acrivon Therapeutics at Acrivon Therapeutics, Inc..
What is Eric Devroe's email address?
AeroLeads has found 1 work email signal at @acrivon.com for Eric Devroe at Acrivon Therapeutics, Inc..
What is Eric Devroe's phone number?
AeroLeads has found 3 phone signal(s) with area code 617, 415 for Eric Devroe at Acrivon Therapeutics, Inc..
Where is Eric Devroe based?
Eric Devroe is based in Greater Boston, United States, United States while working with Acrivon Therapeutics, Inc..
What companies has Eric Devroe worked for?
Eric Devroe has worked for Acrivon Therapeutics, Inc., Xione Therapeutics, Inc., Md Anderson Cancer Center, Opsonix, Inc., and Wyss Institute For Biologically Inspired Engineering.
How can I contact Eric Devroe?
You can use AeroLeads to view verified contact signals for Eric Devroe at Acrivon Therapeutics, Inc., including work email, phone, and LinkedIn data when available.
What schools did Eric Devroe attend?
Eric Devroe holds Ph.D., Biological Chemistry & Molecular Pharmacology from Harvard University.
What skills is Eric Devroe known for?
Eric Devroe is listed with skills including Biotechnology, Drug Discovery, Strategy, Lifesciences, Genomics, Life Sciences, Molecular Biology, and Start Ups.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial